A human trial of an anaesthetic used by some as a party drug could transform the lives of people living with depression where other treatments have failed.
The Royal Adelaide Hospital in partnership with the Central Adelaide Local Health Network, is seeking eligible volunteers to test the world-first, slow-release ketamine tablet.
People living with depression can access a wide array of treatments but up to half experience a form of treatment-resistant symptoms and don't respond well to current medications.
